Man Group »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Man Group

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Man Group from 13F filings

Historical chart of Man Group investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Man Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Man Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.4M 3.9M 1.14
2024-06-30 $5.0M 3.9M 1.29
2024-03-31 $5.9M 5.1M 1.17
2023-12-31 $5.4M 5.3M 1.01
2023-09-30 $7.5M 6.7M 1.12

More positions owned by Man Group

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Amphenol Corp Cl A (APH)
Mastercard Incorporated Cl A (MA)
Qualcomm (QCOM)
Merck & Co (MRK)
Motorola Solutions Com New (MSI)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Man Group

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1